Who is sponsoring NCT03909048?

NCT03909048 is sponsored by University of Alabama at Birmingham.

What drugs are being tested in NCT03909048?

Interventions in NCT03909048: Interactive - Psychoeducation, Non-interactive Psychoeducation.

What condition does NCT03909048 study?

NCT03909048 studies Chronic Low Back Pain.

Is NCT03909048 still recruiting?

NCT03909048 is currently completed. Last updated 31 October 2019.

Last reviewed 2019-10-31 · How we verify

NCT03909048: VRGE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chronic Low Back Pain Graded - Exposure Psychoeducation Intervention

Completed NA Last updated 31 October 2019

What this trial tests

NA trial testing Interactive - Psychoeducation in Chronic Low Back Pain in 40 participants. Completed in 1 September 2019.

Timeline

1 May 2019

Primary endpoint
1 September 2019

1 September 2019

Quick facts

Lead sponsor	University of Alabama at Birmingham
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	40
Start date	1 May 2019
Primary completion	1 September 2019
Estimated completion	1 September 2019
Sites	1 location across United States

Drugs / interventions tested

Interactive - Psychoeducation
Non-interactive Psychoeducation

Conditions studied

Chronic Low Back Pain — all drugs for Chronic Low Back Pain →

Sponsor

University of Alabama at Birmingham

Who can join

Adults 18 to 65, any sex, with Chronic Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will examine the effectiveness of one of two psychoeducation treatments on chronic low back pain.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Virtual Reality in the Treatment of Adults with Chronic Low Back Pain: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Brea-Gómez B, Torres-Sánchez I, Ortiz-Rubio A, Calvache-Mateo A, et al · · 2021 · cited 57× · PMID 34831562 · DOI 10.3390/ijerph182211806

Verify or expand the search:

Other recruiting trials for Chronic Low Back Pain

Currently open trials in the same condition.

NCT07463729 — Evaluation of Stabilization Training With Biofeedback in Lumbosacral Spine Pain Syndrome · NA · recruiting
NCT07415941 — MBM and taVNS for Low Back Pain and Depressive Symptoms · NA · recruiting
NCT06419439 — Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression · Phase 2 · recruiting
NCT07241559 — Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided 5% Dextrose Injection in Chronic Low Back Pain · NA · recruiting
NCT07132762 — The Effect of ESWT Added to Conservative Treatment on Pain, Disability, and Ultrasonographic Outcomes in Chronic Low Bac · NA · recruiting

Other University of Alabama at Birmingham trials

Trials by the same sponsor.

NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis · NA · not yet recruiting
NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis · NA · withdrawn
NCT04768777 — Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis · NA · not yet recruiting
NCT06320951 — VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine · Phase 2 · not yet recruiting
NCT07564934 — Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilit · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03909048 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alabama at Birmingham
Last refreshed: 31 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03909048.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing